Immunotoxins in the treatment of hematologic malignancies.
about
Toxin-based therapeutic approachesNovel decapeptides that bind avidly and deliver radioisotope to colon cancer cellsTrends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.Generation of small 32P-labeled peptides as a potential approach to colorectal cancer therapy.Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.Discovery of internalizing antibodies to tumor antigens from phage libraries.Selection and characterization of cell binding and internalizing phage antibodies.Engineering toxin-resistant therapeutic stem cells to treat brain tumorsCladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders.Targeting malignant B cells with an immunotoxin against ROR1Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.In vivo characterization of fusion protein comprising of A1 subunit of Shiga toxin and human GM-CSF: Assessment of its immunogenicity and toxicityAntibody-based therapeutics for the treatment of human B cell malignanciesAn update in the use of antibodies to treat glioblastoma multiforme.Targeted toxins in brain tumor therapy.Use of ribosome-inactivating proteins from Sambucus for the construction of immunotoxins and conjugates for cancer therapy.Diphtheria toxin-based targeted toxin therapy for brain tumors.Elderberries: a source of ribosome-inactivating proteins with lectin activity.Conditional protein splicing of α-sarcin in live cells.
P2860
Q27013664-B620AA45-DDD4-4D61-9BA5-AD204D55B73CQ33301319-0E540369-B98A-4A02-B4CC-C912A0B69B45Q33311571-4C90576A-DB59-479F-9023-C440A29C97F4Q33346210-3D89AA02-2773-466E-B995-3C2452E53394Q33808241-997276E3-6D02-440A-9C1D-2BD3E7E86336Q34114794-B1F06D4A-7BD4-44E0-9161-17C5CBDB60E7Q34280931-9537F2E4-1877-40FD-BB40-19EB0F4810CEQ34444939-A4960B45-517B-47F6-83E8-D5D9B24817ABQ35430828-AADCA0EA-D787-48CB-ACBF-B449AFC5D8F2Q35969887-7797C486-38A4-4BA4-8052-8D880B82131EQ36655884-69440946-FC49-4419-AF27-78640C34ED52Q36784613-10A934CB-6EF9-4B16-A849-0786944B2821Q36907540-2BC2316F-D043-47E2-89C9-6DD971724ED1Q37329927-E381276C-AD03-4878-9271-3DCA50F44ACEQ37954275-9F4767C1-0F44-4C8D-A8E6-6728265EAD19Q37954333-5229DDB3-CA28-4617-8C82-C96DB8B7DBF1Q38108516-85A46F1E-569B-4847-A242-A0F9ADEEA92DQ38342640-0F64279E-E28B-4DD0-BE18-C3610E6451EAQ39028860-D1884EB0-321E-4A42-8267-2A303B94DEC1
P2860
Immunotoxins in the treatment of hematologic malignancies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Immunotoxins in the treatment of hematologic malignancies.
@ast
Immunotoxins in the treatment of hematologic malignancies.
@en
type
label
Immunotoxins in the treatment of hematologic malignancies.
@ast
Immunotoxins in the treatment of hematologic malignancies.
@en
prefLabel
Immunotoxins in the treatment of hematologic malignancies.
@ast
Immunotoxins in the treatment of hematologic malignancies.
@en
P1433
P1476
Immunotoxins in the treatment of hematologic malignancies.
@en
P2093
Ira Pastan
Robert J Kreitman
P304
P356
10.2174/138945006778559139
P577
2006-10-01T00:00:00Z